ADMA Biologics Inc (ADMA)
6.755
+0.02
(+0.37%)
USD |
NASDAQ |
May 03, 14:37
ADMA Biologics 1 Year Total Returns (Daily): 103.9% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | 103.9% |
| May 01, 2024 | 95.03% |
| April 30, 2024 | 94.63% |
| April 29, 2024 | 96.42% |
| April 26, 2024 | 98.48% |
| April 25, 2024 | 93.39% |
| April 24, 2024 | 87.79% |
| April 23, 2024 | 82.68% |
| April 22, 2024 | 73.18% |
| April 19, 2024 | 81.21% |
| April 18, 2024 | 85.63% |
| April 17, 2024 | 80.84% |
| April 16, 2024 | 93.71% |
| April 15, 2024 | 88.05% |
| April 12, 2024 | 92.95% |
| April 11, 2024 | 92.57% |
| April 10, 2024 | 83.03% |
| April 09, 2024 | 81.31% |
| April 08, 2024 | 84.57% |
| April 05, 2024 | 101.6% |
| April 04, 2024 | 95.03% |
| April 03, 2024 | 91.27% |
| April 02, 2024 | 94.56% |
| April 01, 2024 | 97.58% |
| March 28, 2024 | 105.6% |
| Date | Value |
|---|---|
| March 27, 2024 | 103.0% |
| March 26, 2024 | 95.78% |
| March 25, 2024 | 92.47% |
| March 22, 2024 | 109.0% |
| March 21, 2024 | 99.68% |
| March 20, 2024 | 105.2% |
| March 19, 2024 | 99.68% |
| March 18, 2024 | 91.61% |
| March 15, 2024 | 91.37% |
| March 14, 2024 | 86.96% |
| March 13, 2024 | 96.86% |
| March 12, 2024 | 101.3% |
| March 11, 2024 | 100.0% |
| March 08, 2024 | 85.92% |
| March 07, 2024 | 81.18% |
| March 06, 2024 | 82.69% |
| March 05, 2024 | 69.59% |
| March 04, 2024 | 67.25% |
| March 01, 2024 | 55.49% |
| February 29, 2024 | 50.99% |
| February 28, 2024 | 51.55% |
| February 27, 2024 | 58.17% |
| February 26, 2024 | 57.89% |
| February 23, 2024 | 50.29% |
| February 22, 2024 | 49.86% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-64.62%
Minimum
Mar 18 2020
206.7%
Maximum
Dec 28 2022
13.26%
Average
-13.09%
Median
Oct 22 2019
1 Year Total Returns (Daily) Benchmarks
| Vanda Pharmaceuticals Inc | -27.10% |
| ANI Pharmaceuticals Inc | 76.55% |
| Ligand Pharmaceuticals Inc | -3.00% |
| Puma Biotechnology Inc | 86.42% |
| Bristol-Myers Squibb Co | -33.07% |